ARCHIVES

Phase III Ramucirumab Trial Fails Primary Endpoint of PFS

This article is from The Cancer Letter archive.

Vol. 36 No. 10 | October 25, 2013

Download PDF Visit The Full Archive

Related Articles

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

October 13, 2006

Radiotherapy Provides Longer Life To Brain Cancer Patients

May 28, 2010

Recompetitions Of DCT Contracts Okayed

March 3, 1989

Panel Recommends 5-FU/Levamisole For Adjuvant Stage 3 Colon Cancer

April 27, 1990

Groups Urge FDA To Take Action Against Tobacco Products

June 27, 2014

“Evolving Concept” Looks At Appropriate Early Decision Making In Patient Management

September 28, 1984